Liquidia Corporation Is A Biopharmaceutical Company Based In Durhamnorth Carolinathat Specializes In Therapies For Rare Cardiopulmonary Diseasesparticularly Pulmonary Arterial Hypertensionpahand Pulmonary Hypertension Associated With Interstitial Lung Diseaseph Ild The Company Is Dedicated To Addressing Unmet Patient Needs Through Its Proprietary Printaengineering Technologywhich Enhances Drug Delivery Systems Liquidia S Product Lineup Includes Yutrepiaa Ctreprostinilinhalation Powderan Fda Approved Therapy Designed For Dry Powder Inhalation To Improve Patient Compliancethe Company Is Also Developing L606An Investigational Liposomal Treprostinil Formulation For Nebulizer Administrationand Markets A Generic Treprostinil Injection Through Its Subsidiaryliquidia Pahwith A Focus On Innovation And Patient Accessibilityliquidia Aims To Advance Treatments For Patients With High Need Cardiopulmonary Conditions
No conferences found for this company.
| Company Name | Liquidia Technologies Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
